Web questionnaire survey on cancer cachexia: J-EPOCC2

Web questionnaire survey on cancer cachexia: J-EPOCC2 - J-EPOCC2: Japanese Evidence for Patients Of Cancer Cachexia2

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047865

Enrollment

2000

Registered

2022-06-01

Start date

2022-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer cachexia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Doctor who treats cancer patient of drug treatment stage of any of lung, gastric, esophageal, colorectal, liver, biliary, pancreatic cancer in more than 5 cases in the last 3 months Medical staff such as nurses, pharmacists, nutritionist and physical therapists who are involved in cancer treatment (except nurses who work in clinics and clinics) Patients with lung,gastric, esophageal, colorectal, liver, biliary, or pancreatic cancer who have been admitted to a medical institution for cancer treatment within one year and have a history of hospitalization. For patients who have lung, gastric, esophageal, colorectal, liver, biliary or pancreatic cancer and who have been hospitalized or visited a medical institution for cancer treatment within one year, Family of over 20 years old

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
1) Daily assessment and measurement of anorexia and weight loss associated with cancer 2) Treatment status for anorexia and weight loss 3) Understanding and treatment status of cancer cachexia diagnostic criteria	—

Countries

Japan

Contacts

Public ContactYasushi Sasaki

Reno Medical K.K Account Executive

research_support@reno.co.jp03-6859-3421

Outcome results